Healthcare
JBIC invests $10.5m in India-based Takshasila Hospitals
The government-backed Japan Bank for International Cooperation (JBIC) has invested INR630 million ($10.5 million) in India's Takshasila Hospitals, which operates Sakra World Hospital in Bangalore.
China's Longmaster acquires IDG's health site 39.net
Longmaster Information & Technology, a Shenzhen-listed software developer, has bought Chinese healthcare portal 39.net for RMB650 million ($105 million), facilitating an exit for IDG Capital Partners.
PE-backed Monash IVF loses momentum after $298m IPO
Shares in Australian in vitro fertilization company Monash IVF Group slipped below the offering price on the second day of trading, following a A$315.9 million ($298 million) IPO that saw Ironbridge Capital exit the majority of its holding.
China menstruation-tracking app Meet You raises $35m
SIG Asia Investment has led a $35 million Series C round of funding for Meet You, a Chinese menstrual health mobile app, with participation from Matrix Partners and China Renaissance K2 Ventures.
Riverside buys Australia orthopedics business
Global mid-market buyout firm The Riverside Company has acquired Global Orthopaedic Technologies (GOT), an Australian orthopaedic implants manufacturer.
CDH, China Grand Pharma buy control of contact lens maker
CDH Investments has teamed up with Hong Kong-listed China Grand Pharmaceutical & Healthcare to acquire a 71.25% stake in contact lens maker Shanghai Weicon Optical for $78.75 million.
PE-owned Luye Pharma seeks up to $764m in HK IPO
Luye Pharma Group - a Chinese drugmaker backed by GIC Private, CDH Investments, CITIC Private Equity and New Horizon Capital - is seeking to raise up to 764 million from a Hong Kong IPO.
TPG, Carlyle favor IPO exit for Australia's Healthscope – report
TPG Capital and The Carlyle Group are reportedly looking to take Healthscope public rather than seek to exit Australia’s second-largest private hospital operator via a trade sale.
Carlyle to acquire Japan's Sunsho Pharmaceutical
The Carlyle Group has agreed to acquire Sunsho Pharmaceutical, a contract manufacturer in the Japan's health and nutrition (H&N) industry. The financial details of the transaction - which will see the PE firm take a 100% stake - were not disclosed.
Milestone leads $35m Series B round for JHL Biotech
Milestone Capital has led a $35 million Series B round of investment for JHL Biotech, a Taiwan-based biopharmaceutical company.
OPIC backs Quadria healthcare fund, CX India mezzanine vehicle
The Overseas Private Investment Corporation (OPIC) has made commitments to Quadria Capital South and Southeast Asia-focused healthcare fund and CX Partners’ India mezzanine fund.
Japan's Meiji acquires India drug maker, Temasek exits
Japanese conglomerate Meiji Holdings has acquired Medreich, an Indian pharmaceutical company backed by Singapore sovereign wealth fund Temasek Holdings, for $290 million via its subsidiary Meiji Seika Pharma.
Peepul Capital backs India's Cura Healthcare
India-focused Peepul Capital has invested $6 million in Cura Healthcare, a high-end radiology equipment maker.
Bain-backed Emcure Pharma withdraws IPO
Emcure Pharmaceuticals, the Indian drugs developer backed by Bain Capital, has withdrawn its plans to go public. The listing - which was to raise INR5 billion ($84 million) - is the fourth PE-backed IPO to be pulled in India this year.
China menstruation-tracking app gets $30m Series C round
Ceyuan Ventures has led a $30 million Series C round of investment in Dayima.com, a Chinese menstruation cycle-tracking mobile app.
Australia's Ironbridge set for partial exit from Monash IVF
Australian GP Ironbridge Capital is on course to exit the majority of its stake in Monash IVF through an IPO.
SIGVC invests in China Resources' online drug platform
Shanghai International Group Venture Capital (SIGVC) has provided a RMB300 million ($48 million) Series A round funding for J1.com, an online drug store launched by China Resources Holdings.
China to ease curbs on foreign investment in hospitals
China is to relax limits on foreign investment in joint-venture (JV) hospitals as part of efforts to deepen its healthcare reform.
AIP Japan to launch $300m healthcare focused fund
Asia Investment Partners (AIP) Japan is launching its sixth healthcare-focused fund, which will specifically target the elderly care home segment.
Accel-backed India medical advisory service bought by Ebix
Healthcare Magic, an India-based medical advisory service that won early backing from Accel Partners, has been acquired by NASDAQ-listed on-demand software and e-commerce services provider Ebix.
Hony completes $569m sell down of CSPC Pharma
Hony Capital has made a partial exit from Chinese generic drugs maker CSPC Pharmaceutical Group, generating HK$4.41 billion ($569 million).
Yunfeng raises more than $1b for China fund
Yunfeng Capital, a Chinese PE firm set up by Jack Ma and David Yu, founders of Alibaba Group and Target Media, respectively, has reached a final close of around $1.1 billion on its second fund.
IMC PE unit invests in Singapore's Q&M Dental
Heritas Helios Investments (HHI), a healthcare PE fund seeded by Singaporean conglomerate IMC, has acquired a 10% stake in Q&M Dental Group from existing shareholders for S$30 million ($24 million).
Japan's INCJ joins $8.2m deal for TB vaccine developer
The Innovation Network Corporation of Japan has made a joint investment with Osaka-based Dainippon Sumitomo Pharma and Japan BCG Laboratory in Create Vaccine Company, which is developing a new tuberculosis (TB) vaccine.